Big Fine Over Bextra Promotion
Pfizer to Pay Big Fine. Drug maker Pfizer, Inc. led the news with two announcements this week: It took a record-breaking hit of $2.3 billion over investigations into its improper marketing of the painkiller Bextra and other medications and it is acquiring its rival, Wyeth, for $68 billion, reported Bloomberg … [Read more...]
Arizona Bextra Lawsuit Charges Pfizer
Arizona Bextra Lawsuit Charges Pfizer In 2005, the U.S. Food and Drug Administration (FDA) and European regulators formally asked Pfizer, Inc. to suspend sales of Bextra in the United States and Europe. As a result, Pfizer announced it would halt sales of the drug in the United States and the European Union countries immediately. The … [Read more...]
Pfizer Bextra, Celebrex Settlement
Pfizer Bextra, Celebrex Settlement. Pfizer has reached a tentative agreement to settle lawsuits involving its Bextra and Celebrex painkillers for $894 million. If it goes forward, the Pfizer Bextra and Celebrex settlement will resolve roughly 90 percent of the personal injury lawsuits the company faces because of the … [Read more...]
Celebrex, Bextra Settlements Negotiation
Pfizer Celebrex, Bextra Settlements. Celebrex and Bextra maker Pfizer Inc. has begun to settle injury claims against the painkillers. It is estimated that between 7,000 and 9,000 Celebrex and Bextra cases have been filed by people who claim the defective painkillers caused heart attacks and strokes. According to a report in Friday's … [Read more...]
Life-Threatening Bextra Side Effects
Bextra Side Effects Injury Lawsuits. Pfizer Inc.'s pain pill Bextra should be kept off the market permanently because of potentially life-threatening side effects, federal regulators said Wednesday. Food and Drug Administration staff members concluded that the drug has greater health risks than similar painkillers, including … [Read more...]
Health Canada Bans Bextra Sales
Pfizer's Bextra Was Removed From The Market. The era of the COX-2 inhibitors appears to be coming to an end. Vioxx was removed from the market worldwide by Merck in September 2004. Pfizer has announced Celebrex is about to undergo new safety testing while the company’s other COX-2 inhibitor, Bextra, was removed from the market in … [Read more...]
FDA Bans Bextra Painkiller Sale
Bextra Risk Of Heart Attack And Skin Conditions. The Food and Drug Administration has followed the US FDA's lead by banning the sale of Bextra, a kind of painkiller for joint aches which puts users at risk of heart attack and skin conditions. The US FDA on April 7 asked Pfizer to withdraw ‘Bextra’ from the market and announced … [Read more...]
Pfizer Pulls Bextra From UAE
Pfizer Pulls Bextra. Pfizer has decided to also follow the US Food and Drug Administration ruling in the United Arab Emirates and withdraw its painkiller Bextra. Risks To The Heart And Stomach The company still hopes that the drug may be re-introduced but the FDA said its risks to the heart and stomach outweighed potential … [Read more...]
HSA Suspends Bextra Sales in Singapore
Pfizer’s Bextra Banned In Singapore. Singapore has suspended the sales of ‘Bextra’, an anti-inflammatory drug produced by the global pharmaceutical manufacturer Pfizer. Study shows that taking ‘Bextra’ may pose risk to patients' cardiovascular safety or incur rare but serious skin reactions, which have led to similar bans on the … [Read more...]
FDA Tells Pfizer To Pull Bextra Off Market
Bextra Black Box Warning. Food and Drug Administration officials Thursday told Pfizer Inc. to take its COX-2 drug Bextra off the U.S. market and put a warning on Celebrex. The FDA, based on recommendations from its Arthritis and Drug Safety and Risk Management Advisory Committee following a hearing in February, also asked … [Read more...]
Popular Pain Killer Warnings
Pain Killers Can Cause Heart Problems. The American Heart Association is weighing in on the controversy surrounding the link between pain killers and heart problems, offering its own recommendations for patients taking prescription medications like Celebrex and Bextra. Their recommendation is to use the drug with the fewest known … [Read more...]
Study: 3 Painkillers’ Heart Risk
Painkillers' Heart Risk. A new study has linked painkillers Vioxx, Celebrex and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs. Vioxx and Celebrex increased patients' risk of heart attack and stroke by about 20 percent … [Read more...]
HMO Bans Bextra Until Safety is Proven
Heart Risks Associated With Bextra. Kaiser Permanente, the nation's largest not-for-profit managed-care provider, has stopped prescribing Bextra until tests show whether the painkiller is safe. The decision came amid "compelling" evidence of heightened heart risks associated with Bextra and a similar drug called Vioxx that … [Read more...]
Consumer Advocates Urge Pulling 2 Drugs off Market
Two Drugs Are Being Pulled Off The Market. The Food and Drug Administration should immediately yank Celebrex and Bextra from the market to protect Americans from the drugs' heart risks, according to a petition filed with the agency yesterday by Public Citizen. The petition also requests that the FDA freeze applications for Arcoxia … [Read more...]
Putting Out A Warning On A Stealthy Reaction
FDA Changed The Warning Label On Bextra To Emphasize The Stealthy Reaction. The FDA has just changed the warning label on the pain reliever Bextra to emphasize the risk of a rare but potentially fatal "skin reaction," Stevens-Johnson syndrome. Calling Stevens-Johnson syndrome a "skin reaction" is like talking about headaches when … [Read more...]
Safety Information Regarding Selective COX-2 Inhibitor NSAIDs
Selective COX-2 Inhibitor NSAIDs Safety Information. Health Canada wishes to inform Canadians of safety concerns regarding the group of drugs known as selective COX-2 inhibitor NSAIDs (non-steroidal anti-inflammatories). These include Vioxx (rofecoxib), which has been withdrawn from the market, Celebrex (celecoxib), … [Read more...]
EMEA Statement On Valdecoxib & Parecoxib Sodium
Valdecoxib New Safety Information. Cardiovascular Risks In Coronary Artery Bypass Graft (Cabg) Surgery And Serious Adverse Skin Reactions. The European Medicines Agency (EMEA) and its Scientific Committee for human medicines have been made aware of new safety information on cardiovascular and serious skin adverse events in relation … [Read more...]
Suit Charging Bextra was Responsible for Cardiac Death
Bextra Blamed For Cardiac Death. Parker & Waichman, LLP and Seeger Weiss LLP have filed a case in Supreme Court of the State of New York, County of New York against Pfizer, Inc (NYSE:PFE). The case is on behalf of the estate of a 46 year old New Jersey resident who died of a heart attack after using ‘Bextra’. The suit … [Read more...]
Improper Pharmacia Marketing
Pharmacia Corp. Improper Marketing. A consumer group sued Pharmacia Corp. over its promotion of the pain drug Bextra, alleging that the pharmaceutical company is circumventing federal marketing regulations. The Congress of California Seniors filed the suit in California Superior Court in Los Angeles on Monday, alleging … [Read more...]
FDA, Pharmacia Update Bextra Label W/ New Warnings
Bextra Label New Warnings. FDA and Pharmacia are advising health care professionals about new warnings and information in the product labeling of the drug Bextra (valdecoxib), a drug approved for treatment of osteoarthritis, rheumatoid arthritis and dysmenorrhea (menstrual pain). The labeling is being updated with new warnings … [Read more...]
